• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    life science investing

    US Lawmakers Dedicate Over US$8 Billion to Coronavirus Outbreak

    Danielle Edwards
    Mar. 04, 2020 04:30PM PST
    Life Science Investing News
    Life Science Investing

    US lawmakers approved an emergency plan, providing US$8.3 billion to combat the spread of the disease.

    The US is throwing its support behind the relief for the increasing threat of the COVID-19 coronavirus global outbreak. 

    On Wednesday (March 4), the US federal power approved an emergency plan making available US$8.3 billion to be provided in combating the disease spreading.

    According to Senate Appropriations Committee Chairman Richard Shelby, 85 percent of the funding will be used domestically.

    The funding comes after days of negotiations on Capitol Hill as the concerns about the virus spreading across the US have grown.

    As of Wednesday afternoon, the Centers for Disease Control and Prevention noted that 80 cases of the flu-like COVID-19 illness have been reported in the US across 13 different states.

    “This should not be about politics; this is about doing our job to protect the American people from a potential pandemic,” Shelby said.

    The bill includes over US$3 billion for research and developing vaccines, therapeutics and diagnostic tests, as well as US$2.2 billion of public health funding for prevention and preparedness efforts. US$1.25 billion will be used to address the disease abroad and about US$1 billion will go towards medical supplies and medical surge capacity.

    “We worked together to craft an aggressive and comprehensive response that provides the resources the experts say they need to combat this crisis,” Shelby added.

    A Democratic House aide said the emergency bill also provides more than US$300 million to “help ensure that, when a vaccine is developed, Americans can receive it regardless of their ability to pay,” according to a report from CNBC.

    The emergency funding follows the decision from the US Federal Reserve to cut interest rates by half a percentage point to support the American economy, lowering the benchmark rate to 1 to 1.25 percent.

    Don’t forget to follow @INN_LifeScience for real-time updates!

    Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

    life science investingrichard shelby
    The Conversation (0)

    Go Deeper

    AI Powered
    Astria Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

    Astria Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

    Test tubes.

    Biotech Market Forecast: Top Trends for Biotech in 2025

    Latest News

    Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing News Stocks

    Defence Therapeutics Class A

    DTC:CC

    Cloud DX

    CDX:CA

    BioHarvest Sciences

    BHSC:CNX

    Billy Goat Brands

    GOAT:CC

    Contakt World

    HELP:CNX
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×